---
layout: default
title: "ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection"
---

# ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2510.26703" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2510.26703v1</a>
  <a href="https://arxiv.org/pdf/2510.26703.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.26703v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2510.26703v1', 'ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Paul F. R. Wilson, Mohamed Harmanani, Minh Nguyen Nhat To, Amoon Jamzad, Tarek Elghareb, Zhuoxin Guo, Adam Kinnaird, Brian Wodlinger, Purang Abolmaesumi, Parvin Mousavi

**åˆ†ç±»**: eess.IV, cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-10-30

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**ProstNFound+ï¼šåˆ©ç”¨åŒ»å­¦åŸºç¡€æ¨¡å‹å®ç°å‰åˆ—è…ºç™Œå¾®è¶…å£°æ£€æµ‹çš„å‰ç»æ€§ç ”ç©¶**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `å‰åˆ—è…ºç™Œæ£€æµ‹` `åŒ»å­¦åŸºç¡€æ¨¡å‹` `å¾®è¶…å£°` `é€‚é…å™¨è°ƒä¼˜` `æç¤ºå­¦ä¹ ` `å‰ç»æ€§ç ”ç©¶` `ä¸´åºŠåº”ç”¨`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰å‰åˆ—è…ºç™Œæ£€æµ‹æ–¹æ³•ä¾èµ–ä¸“å®¶ç»éªŒï¼Œå­˜åœ¨ä¸»è§‚æ€§å’Œå¯æ‰©å±•æ€§é—®é¢˜ï¼Œç¼ºä¹å®¢è§‚ã€é«˜æ•ˆçš„è¯Šæ–­å·¥å…·ã€‚
2. ProstNFound+åˆ©ç”¨åŒ»å­¦åŸºç¡€æ¨¡å‹ï¼Œç»“åˆé€‚é…å™¨è°ƒä¼˜å’Œå®šåˆ¶æç¤ºç¼–ç å™¨ï¼ŒåµŒå…¥ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œç”Ÿæˆç™Œç—‡çƒ­å›¾å’Œé£é™©è¯„åˆ†ã€‚
3. å‰ç»æ€§ç ”ç©¶è¡¨æ˜ï¼ŒProstNFound+å…·æœ‰è‰¯å¥½çš„æ³›åŒ–èƒ½åŠ›ï¼Œä¸ä¸´åºŠè¯„åˆ†ä¸€è‡´ï¼Œå¹¶ç”Ÿæˆå¯è§£é‡Šçš„çƒ­å›¾ï¼Œå…·æœ‰ä¸´åºŠéƒ¨ç½²æ½œåŠ›ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æœ¬ç ”ç©¶æ—¨åœ¨æ¢ç´¢åŒ»å­¦åŸºç¡€æ¨¡å‹ï¼ˆFMsï¼‰åœ¨æ„å»ºé«˜æ€§èƒ½è¯Šæ–­ç³»ç»Ÿä¸­çš„æ½œåŠ›ï¼Œå¹¶é¦–æ¬¡åœ¨ä¸´åºŠç¯å¢ƒä¸­æµ‹è¯•å…¶åœ¨å‰åˆ—è…ºç™Œï¼ˆPCaï¼‰å¾®è¶…å£°ï¼ˆÎ¼USï¼‰æ£€æµ‹ä¸­çš„åº”ç”¨ã€‚æˆ‘ä»¬æå‡ºäº†ProstNFound+ï¼Œä¸€ä¸ªé’ˆå¯¹Î¼USçš„PCaæ£€æµ‹çš„FMæ”¹è¿›æ¨¡å‹ï¼Œå¹¶å¯¹å…¶è¿›è¡Œäº†é¦–æ¬¡å‰ç»æ€§éªŒè¯ã€‚ProstNFound+ç»“åˆäº†åŒ»å­¦FMã€é€‚é…å™¨è°ƒä¼˜å’Œä¸€ä¸ªå®šåˆ¶çš„æç¤ºç¼–ç å™¨ï¼Œè¯¥ç¼–ç å™¨åµŒå…¥äº†PCaç‰¹å¼‚æ€§çš„ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ã€‚è¯¥æ¨¡å‹ç”Ÿæˆç™Œç—‡çƒ­å›¾å’Œä¸´åºŠæ˜¾è‘—PCaçš„é£é™©è¯„åˆ†ã€‚åœ¨å¤šä¸­å¿ƒå›é¡¾æ€§æ•°æ®ä¸Šè®­ç»ƒåï¼Œè¯¥æ¨¡å‹åœ¨äº”å¹´åä»ä¸€ä¸ªæ–°çš„ä¸´åºŠç«™ç‚¹è·å¾—çš„æ•°æ®ä¸Šè¿›è¡Œå‰ç»æ€§è¯„ä¼°ã€‚æ¨¡å‹é¢„æµ‹ä¸æ ‡å‡†ä¸´åºŠè¯„åˆ†åè®®ï¼ˆPRI-MUSå’ŒPI-RADSï¼‰è¿›è¡ŒåŸºå‡†æµ‹è¯•ã€‚ç»“æœè¡¨æ˜ï¼ŒProstNFound+å¯¹å‰ç»æ€§æ•°æ®è¡¨ç°å‡ºå¼ºå¤§çš„æ³›åŒ–èƒ½åŠ›ï¼Œä¸å›é¡¾æ€§è¯„ä¼°ç›¸æ¯”æ²¡æœ‰æ€§èƒ½ä¸‹é™ã€‚å®ƒä¸ä¸´åºŠè¯„åˆ†å¯†åˆ‡ç›¸å…³ï¼Œå¹¶äº§ç”Ÿä¸æ´»æ£€ç¡®è®¤çš„ç—…å˜ä¸€è‡´çš„å¯è§£é‡Šçƒ­å›¾ã€‚ç»“æœçªå‡ºäº†å…¶ä¸´åºŠéƒ¨ç½²çš„æ½œåŠ›ï¼Œä¸ºä¸“å®¶é©±åŠ¨çš„åè®®æä¾›äº†ä¸€ç§å¯æ‰©å±•ä¸”å¯è§£é‡Šçš„æ›¿ä»£æ–¹æ¡ˆã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³å‰åˆ—è…ºç™Œå¾®è¶…å£°å›¾åƒï¼ˆÎ¼USï¼‰æ£€æµ‹ä¸­ï¼Œç°æœ‰æ–¹æ³•ä¾èµ–ä¸“å®¶ç»éªŒã€ä¸»è§‚æ€§å¼ºã€å¯æ‰©å±•æ€§å·®çš„é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•éš¾ä»¥å……åˆ†åˆ©ç”¨ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œä¸”ç¼ºä¹å¯¹æ–°ä¸´åºŠç¯å¢ƒçš„æ³›åŒ–èƒ½åŠ›ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯åˆ©ç”¨åŒ»å­¦åŸºç¡€æ¨¡å‹ï¼ˆFMsï¼‰çš„å¼ºå¤§è¡¨å¾èƒ½åŠ›ï¼Œé€šè¿‡é€‚é…å™¨è°ƒä¼˜å’Œå®šåˆ¶æç¤ºç¼–ç å™¨ï¼Œå°†ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©èå…¥æ¨¡å‹ï¼Œä»è€Œæé«˜å‰åˆ—è…ºç™Œæ£€æµ‹çš„å‡†ç¡®æ€§å’Œæ³›åŒ–èƒ½åŠ›ã€‚è¿™ç§æ–¹æ³•æ—¨åœ¨å‡å°‘å¯¹ä¸“å®¶ç»éªŒçš„ä¾èµ–ï¼Œå¹¶æä¾›æ›´å®¢è§‚ã€å¯è§£é‡Šçš„è¯Šæ–­ç»“æœã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šProstNFound+çš„æ•´ä½“æ¶æ„åŒ…æ‹¬ä¸‰ä¸ªä¸»è¦æ¨¡å—ï¼š1) åŒ»å­¦åŸºç¡€æ¨¡å‹ï¼ˆMedical FMï¼‰ï¼šåˆ©ç”¨é¢„è®­ç»ƒçš„åŒ»å­¦å›¾åƒæ¨¡å‹ä½œä¸ºç‰¹å¾æå–å™¨ã€‚2) é€‚é…å™¨è°ƒä¼˜ï¼ˆAdapter Tuningï¼‰ï¼šé€šè¿‡å°‘é‡æ•°æ®å¾®è°ƒFMï¼Œä½¿å…¶é€‚åº”å‰åˆ—è…ºç™ŒÎ¼USå›¾åƒçš„ç‰¹ç‚¹ã€‚3) æç¤ºç¼–ç å™¨ï¼ˆPrompt Encoderï¼‰ï¼šå°†PCaç‰¹å¼‚æ€§çš„ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ç¼–ç ä¸ºæç¤ºä¿¡æ¯ï¼Œå¼•å¯¼æ¨¡å‹å…³æ³¨å…³é”®åŒºåŸŸã€‚æ¨¡å‹æœ€ç»ˆç”Ÿæˆç™Œç—‡çƒ­å›¾å’Œé£é™©è¯„åˆ†ã€‚

**å…³é”®åˆ›æ–°**ï¼šè¯¥è®ºæ–‡çš„å…³é”®åˆ›æ–°åœ¨äºå°†åŒ»å­¦åŸºç¡€æ¨¡å‹ä¸é€‚é…å™¨è°ƒä¼˜å’Œå®šåˆ¶æç¤ºç¼–ç å™¨ç›¸ç»“åˆï¼Œç”¨äºå‰åˆ—è…ºç™Œå¾®è¶…å£°å›¾åƒçš„æ£€æµ‹ã€‚é€šè¿‡æç¤ºç¼–ç å™¨åµŒå…¥ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œå¢å¼ºäº†æ¨¡å‹çš„åˆ¤åˆ«èƒ½åŠ›å’Œå¯è§£é‡Šæ€§ã€‚æ­¤å¤–ï¼Œè¯¥ç ”ç©¶è¿›è¡Œäº†å‰ç»æ€§éªŒè¯ï¼Œè¯æ˜äº†æ¨¡å‹åœ¨æ–°çš„ä¸´åºŠç¯å¢ƒä¸­çš„æ³›åŒ–èƒ½åŠ›ã€‚

**å…³é”®è®¾è®¡**ï¼šæç¤ºç¼–ç å™¨çš„è®¾è®¡æ˜¯å…³é”®ã€‚å®ƒå°†ä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©ï¼ˆä¾‹å¦‚ï¼Œè‚¿ç˜¤å¤§å°ã€ä½ç½®ã€å½¢æ€ç­‰ï¼‰ç¼–ç æˆå‘é‡ï¼Œå¹¶å°†å…¶ä½œä¸ºæç¤ºä¿¡æ¯è¾“å…¥åˆ°åŒ»å­¦åŸºç¡€æ¨¡å‹ä¸­ã€‚é€‚é…å™¨è°ƒä¼˜é‡‡ç”¨å°‘é‡æ•°æ®è¿›è¡Œå¾®è°ƒï¼Œé¿å…äº†ç¾éš¾æ€§é—å¿˜ã€‚æŸå¤±å‡½æ•°åŒ…æ‹¬åˆ†ç±»æŸå¤±ï¼ˆåŒºåˆ†ç™Œæ€§å’Œéç™Œæ€§åŒºåŸŸï¼‰å’Œå›å½’æŸå¤±ï¼ˆé¢„æµ‹é£é™©è¯„åˆ†ï¼‰ã€‚å…·ä½“ç½‘ç»œç»“æ„ç»†èŠ‚æœªçŸ¥ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

ProstNFound+åœ¨å‰ç»æ€§æ•°æ®ä¸Šè¡¨ç°å‡ºå¼ºå¤§çš„æ³›åŒ–èƒ½åŠ›ï¼Œä¸å›é¡¾æ€§è¯„ä¼°ç›¸æ¯”æ²¡æœ‰æ€§èƒ½ä¸‹é™ã€‚æ¨¡å‹é¢„æµ‹ä¸æ ‡å‡†ä¸´åºŠè¯„åˆ†åè®®ï¼ˆPRI-MUSå’ŒPI-RADSï¼‰å¯†åˆ‡ç›¸å…³ï¼Œå¹¶ç”Ÿæˆä¸æ´»æ£€ç¡®è®¤çš„ç—…å˜ä¸€è‡´çš„å¯è§£é‡Šçƒ­å›¾ã€‚è¿™äº›ç»“æœè¡¨æ˜ProstNFound+å…·æœ‰ä¸´åºŠéƒ¨ç½²çš„æ½œåŠ›ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

ProstNFound+å¯åº”ç”¨äºå‰åˆ—è…ºç™Œçš„æ—©æœŸç­›æŸ¥å’Œè¯Šæ–­ï¼Œè¾…åŠ©åŒ»ç”Ÿè¿›è¡Œå†³ç­–ï¼Œæé«˜è¯Šæ–­å‡†ç¡®æ€§å’Œæ•ˆç‡ã€‚è¯¥æ¨¡å‹å…·æœ‰å¯æ‰©å±•æ€§ï¼Œå¯éƒ¨ç½²åœ¨ä¸åŒçš„ä¸´åºŠç¯å¢ƒä¸­ï¼Œä¸ºæ‚£è€…æä¾›æ›´ä¾¿æ·ã€å®¢è§‚çš„è¯Šæ–­æœåŠ¡ã€‚æœªæ¥ï¼Œè¯¥æ¨¡å‹å¯ä¸å…¶ä»–ä¸´åºŠæ•°æ®ï¼ˆå¦‚MRIã€æ´»æ£€ç»“æœï¼‰ç»“åˆï¼Œå®ç°æ›´å…¨é¢çš„å‰åˆ—è…ºç™Œé£é™©è¯„ä¼°ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Purpose: Medical foundation models (FMs) offer a path to build high-performance diagnostic systems. However, their application to prostate cancer (PCa) detection from micro-ultrasound (Î¼US) remains untested in clinical settings. We present ProstNFound+, an adaptation of FMs for PCa detection from Î¼US, along with its first prospective validation. Methods: ProstNFound+ incorporates a medical FM, adapter tuning, and a custom prompt encoder that embeds PCa-specific clinical biomarkers. The model generates a cancer heatmap and a risk score for clinically significant PCa. Following training on multi-center retrospective data, the model is prospectively evaluated on data acquired five years later from a new clinical site. Model predictions are benchmarked against standard clinical scoring protocols (PRI-MUS and PI-RADS). Results: ProstNFound+ shows strong generalization to the prospective data, with no performance degradation compared to retrospective evaluation. It aligns closely with clinical scores and produces interpretable heatmaps consistent with biopsy-confirmed lesions. Conclusion: The results highlight its potential for clinical deployment, offering a scalable and interpretable alternative to expert-driven protocols.

